
Pharmacology, pharmacogenomics, drug discovery and design, drug therapy [125]


Virgile Andreani
InBio: Experimental and Computational Methods for Modeling Cellular Processes
Physicist and computer scientist by training, I develop quantitative population models of antibiotic resistance, which I calibrate using optimal experimental design. I then exploit them to engineer optimal treatment strategies.

David Clement
Organic Chemistry

Dorian Obino
Pathogenesis of vascular infections

GDSCTools: drug discovery
Thomas Cokelaer

Olivier Sperandio
Chemoinformatics and proteochemometrics

Mechanism of ageing and progeroid diseases
Miria Ricchetti

A synthetic carbohydrate-based conjugate vaccine ready for a clinical trial
Laurence Mulard

Group : Medicinal Chemistry
Yves Janin

Bioorganic chemistry of nucleic acids
Marcel Hollenstein

Pharmacological prevention and treatment of long-term cognitive and behavioral effects of neuroinflammation
Franck Verdonk • Raphael Gaillard • Fabrice Chretien

Damien Rei
Perception and Memory
I study the role of stress as a risk factor for the development of neurodegenerative and psychiatric diseases (Alzheimer’s and Parkinson’s diseases, bipolar and major depression disorders and others) and the neurocircuits implicated. One […]

Juan Manuel Coya Raboso
I earned my PhD in Biochemistry, Molecular Biology and Biomedicine at the Prof. Cristina Casals’ laboratory at the Complutense University of Madrid, Spain. Prior to my thesis, I worked in different research centers in […]

Damien Maura
Bacteriophage, bacterium, host

Silence to cure: stabilize chromatin for the management of diseases with inflammatory components
Christian Muchardt

Guilherme Dias de Melo
Trypanosomatids Infectious Processes
Guilherme Dias de Melo is veterinarian. He obtained his degree in Veterinary Medicine (december 2010), his MD in Veterinary Sciences (june 2012) and his PhD in Veterinary Sciences (june 2015) at the Sao Paulo […]